Teligent, a New Jersey-based specialty generic pharma company, has opened a pharmaceutical product development laboratory in Estonia. The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company’s North American markets. The 3,000-square foot facility also includes administrative space for quality assurance and supply chain employees who oversee the company’s third-party contract manufacturing activities around the world. ...